Cargando…

Pharmacogenomic incidental findings in 308 families: The NIH Undiagnosed Disease Program experience

PURPOSE: Using SNP chip and exome sequence data from individuals participating in the NIH Undiagnosed Diseases Program (UDP), we evaluated the number and therapeutic informativeness of incidental pharmacogenetic variants. METHODS: Pharmacogenomics Knowledgebase (PharmGKB) annotated sequence variants...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Elizabeth M.J., Xu, Karen, Mosbrook, Emma, Links, Amanda, Guzman, Jessica, Adams, David R., Flynn, Elise, Valkanas, Elise, Toro, Camillo, Tifft, Cynthia J., Boerkoel, Cornelius F., Gahl, William A., Sincan, Murat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133159/ https://www.ncbi.nlm.nih.gov/pubmed/27253732 http://dx.doi.org/10.1038/gim.2016.47

Ejemplares similares

The implications of familial incidental findings from exome sequencing: The NIH Undiagnosed Diseases Program experience
por: Lawrence, Lauren, et al.
Publicado: (2014)

The NIH Undiagnosed Diseases Program: bonding scientists and clinicians
por: Gahl, William A., et al.
Publicado: (2012)

Distributed Cognition and Process Management Enabling Individualized Translational Research: The NIH Undiagnosed Diseases Program Experience
por: Links, Amanda E., et al.
Publicado: (2016)

Defining Disease, Diagnosis, and Translational Medicine within a Homeostatic Perturbation Paradigm: The National Institutes of Health Undiagnosed Diseases Program Experience
por: Gall, Timothy, et al.
Publicado: (2017)

The Undiagnosed Diseases Program Integrated Collaboration System (UDPICS): One Program’s Experience Developing Custom Software to Support Research for Complex-Disease Families
por: Guzman, Jessica, et al.
Publicado: (2015)

Computational evaluation of exome sequence data using human and model organism phenotypes improves diagnostic efficiency
por: Bone, William P., et al.
Publicado: (2016)

Adults with lysosomal storage diseases in the undiagnosed diseases network
por: Xiao, Changrui, et al.
Publicado: (2022)

The undiagnosed diseases program: Approach to diagnosis
por: Macnamara, Ellen F., et al.
Publicado: (2020)

Replicate exome-sequencing in a multiple-generation family: improved interpretation of next-generation sequencing data
por: Cherukuri, Praveen F., et al.
Publicado: (2015)

Incidental Finding of an Undiagnosed Coarctation of the Aorta Causing Dilated Cardiomyopathy in an Adult
por: Ibrahim, Abdalla, et al.
Publicado: (2017)

Clinical sites of the Undiagnosed Diseases Network: Unique contributions to genomic medicine and science
por: Schoch, Kelly, et al.
Publicado: (2020)

Incidental Detection of Internal Jugular Vein Thrombosis Secondary to Undiagnosed Benign Substernal Goiter
por: Lønnebakken, Mai Tone, et al.
Publicado: (2010)

International Undiagnosed Diseases Programs (UDPs): components and outcomes
por: Curic, Ela, et al.
Publicado: (2023)

An incidental finding of a right atrial myxoma with undiagnosed Ebstein anomaly: a case report
por: McClenaghan, Lisa, et al.
Publicado: (2023)

Osteolytic Lesion of the Maxilla in an Undiagnosed Multiple Myeloma Patient Identified Incidentally by Cone Beam Computed Tomography
por: Ali, Sarah AlFarabi, et al.
Publicado: (2022)

GRIN2A mutation and early-onset epileptic encephalopathy: personalized therapy with memantine
por: Pierson, Tyler Mark, et al.
Publicado: (2014)

New NIH Director
Publicado: (1993)

The NIH ENDGAME Consortium
Publicado: (2006)

Undiagnosed diseases: Needs and opportunities in 20 countries participating in the Undiagnosed Diseases Network International
por: Taruscio, Domenica, et al.
Publicado: (2023)

Rescoring the NIH Chronic Prostatitis Symptom Index (NIH-CPSI): Nothing New
por: Clemens, J. Quentin, et al.
Publicado: (2009)

The undiagnosed potential clinically significant incidental findings of neck CTA: A large retrospective single-center study
por: Chen, Guangliang, et al.
Publicado: (2020)

The Role of Nuclear Bodies in Gene Expression and Disease
por: Morimoto, Marie, et al.
Publicado: (2013)

Pharmacogenomics
Publicado: (2008)

Pharmacogenomics
Publicado: (2008)

Initiating an undiagnosed diseases program in the Western Australian public health system
por: Baynam, Gareth, et al.
Publicado: (2017)

Consistent terminology for medication-related problems in pharmacogenomic cases
por: Polasek, Thomas M., et al.
Publicado: (2023)

Developing genomic knowledge bases and databases to support clinical management: current perspectives
por: Huser, Vojtech, et al.
Publicado: (2014)

NIH Roadmap for Medical Research.
por: Schmidt, Charles W
Publicado: (2004)

The NIH Blueprint for Neuroscience Research
Publicado: (2006)

Estimating the NIH Efficient Frontier
por: Bisias, Dimitrios, et al.
Publicado: (2012)

Kuru: memories of the NIH years
por: Asher, David M.
Publicado: (2008)

NIH Roadmap for Medical Research
por: Kantor, Lori Wolfgang
Publicado: (2008)

NIH funding longevity by gender
por: Hechtman, Lisa A., et al.
Publicado: (2018)

THE NIH PATHWAYS TO PREVENTION PROGRAM
por: Shropshire, Keisha L
Publicado: (2019)

Implementing Pharmacogenomics at Your Institution: Establishment and Overcoming Implementation Challenges
por: Arwood, MJ, et al.
Publicado: (2016)

A prospective randomized half-body study: 308 nm LED light vs. 308 nm excimer laser for localized psoriasis
por: Yu, Yingyuan, et al.
Publicado: (2023)

Pharmacogenomics arrives
por: Petsko, Gregory A
Publicado: (2004)

Pharmacogenomic Biomarkers
por: Kirkwood, Sandra C., et al.
Publicado: (2002)

Pharmacogenomics in epilepsy
por: Balestrini, Simona, et al.
Publicado: (2018)

Pharmacogenomics of Antibiotics
por: Stocco, Gabriele, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qutkhlhnqlia7se2hhln132trh